Cargando…

Genomic Alterations in Biliary Tract Cancer Using Targeted Sequencing()

Background: Biliary tract cancers (BTCs) are rare and heterogeneous group of tumors classified anatomically into intrahepatic and extrahepatic bile ducts and gallbladder adenocarcinomas. Patient-derived tumor cell (PDC) models with genome analysis can be a valuable platform to develop a method to ov...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yoo, Kwai Han, Kim, Nayoung K.D., Kwon, Woo Il, Lee, Chung, Kim, Sun Young, Jang, Jiryeon, Ahn, Jungmi, Kang, Mihyun, Jang, Hyojin, Kim, Seung Tae, Ahn, Soomin, Jang, Kee-Taek, Park, Young Suk, Park, Woong-Yang, Lee, Jeeyun, Heo, Jin Seok, Park, Joon Oh
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Neoplasia Press 2016
Materias:	Original article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4856857/ https://www.ncbi.nlm.nih.gov/pubmed/27267833 http://dx.doi.org/10.1016/j.tranon.2016.01.007

Ejemplares similares

Molecular characterization of colorectal cancer patients and concomitant patient-derived tumor cell establishment
por: Song, Haa-Na, et al.
Publicado: (2016)

Molecular Subgroup Analysis of Clinical Outcomes in a Phase 3 Study of Gemcitabine and Oxaliplatin with or without Erlotinib in Advanced Biliary Tract Cancer
por: Kim, Seung Tae, et al.
Publicado: (2015)

Tumour shrinkage at 6 weeks predicts favorable clinical outcomes in a phase III study of gemcitabine and oxaliplatin with or without erlotinib for advanced biliary tract cancer
por: Kim, Seung Tae, et al.
Publicado: (2015)

The implication of FLT3 amplification for FLT targeted therapeutics in solid tumors
por: Lim, Sung Hee, et al.
Publicado: (2016)

PIK3CA mutation detection in metastatic biliary cancer using cell-free DNA
por: Kim, Seung Tae, et al.
Publicado: (2015)

The Clinical Impact of c-MET Over-Expression in Advanced Biliary Tract Cancer (BTC)
por: Heo, Mi Hwa, et al.
Publicado: (2017)

Patient-derived cell models as preclinical tools for genome-directed targeted therapy
por: Lee, Ji Yun, et al.
Publicado: (2015)

The Correlation Between Serum Chemokines and Clinical Outcome in Patients with Advanced Biliary Tract Cancer
por: Lee, Su Jin, et al.
Publicado: (2018)

Efficacy of BRAF Inhibitors in Asian Metastatic Melanoma Patients: Potential Implications of Genomic Sequencing in BRAF-Mutated Melanoma()()
por: Kim, Hee Kyung, et al.
Publicado: (2016)

Neuroendocrine tumor in gastric adenoma: a diagnostic pitfall mimicking invasive adenocarcinoma
por: Lee, Sun-Mi, et al.
Publicado: (2012)

The efficacy of immune checkpoint inhibitors in biliary tract cancer with KRAS mutation
por: Jeong, Sun Young, et al.
Publicado: (2023)

Actionability evaluation of biliary tract cancer by genome transcriptome analysis and Asian cancer knowledgebase
por: Okawa, Yuki, et al.
Publicado: (2021)

Comparison of Three BRAF Mutation Tests in Formalin-Fixed Paraffin Embedded Clinical Samples
por: Ahn, Soomin, et al.
Publicado: (2013)

Vimentin-Positive Circulating Tumor Cells as Diagnostic and Prognostic Biomarkers in Patients with Biliary Tract Cancer
por: Han, Sung Yong, et al.
Publicado: (2021)

Gastrointestinal malignancies harbor actionable MET exon 14 deletions
por: Lee, Jeeyun, et al.
Publicado: (2015)

Isolated Biliary Granulocytic Sarcoma Followed by Acute Myelogeneous Leukemia with Multilineage Dysplasia: A Case Report and Literature Review
por: Sung, Chang Ohk, et al.
Publicado: (2006)

Anti-tumor efficacy of fulvestrant in estrogen receptor positive gastric cancer
por: Yi, Jun Ho, et al.
Publicado: (2014)

Gastroenteropancreatic Neuroendocrine Tumors with Liver Metastases in Korea: A Clinicopathological Analysis of 72 Cases in a Single Institute
por: Shin, Yooju, et al.
Publicado: (2015)

BEZ235 (PIK3/mTOR inhibitor) Overcomes Pazopanib Resistance in Patient-Derived Refractory Soft Tissue Sarcoma Cells
por: Kim, Hee Kyung, et al.
Publicado: (2016)

Accuracy of an administrative database for pancreatic cancer by international classification of disease 10(th) codes: A retrospective large-cohort study
por: Hwang, Young-Jae, et al.
Publicado: (2019)

Acquired resistance to LY2874455 in FGFR2-amplified gastric cancer through an emergence of novel FGFR2-ACSL5 fusion
por: Kim, Sun Young, et al.
Publicado: (2017)

High PD-L1 expression is associated with therapeutic response to pembrolizumab in patients with advanced biliary tract cancer
por: Ahn, Soomin, et al.
Publicado: (2020)

Antitumor Effect of AZD4547 in a Fibroblast Growth Factor Receptor 2–Amplified Gastric Cancer Patient–Derived Cell Model()
por: Jang, Jiryeon, et al.
Publicado: (2017)

Four distinct immune microenvironment subtypes in gastric adenocarcinoma with special reference to microsatellite instability
por: Cho, Junhun, et al.
Publicado: (2018)

Targeted Exome Sequencing Provided Comprehensive Genetic Diagnosis of Congenital Anomalies of the Kidney and Urinary Tract
por: Ahn, Yo Han, et al.
Publicado: (2020)

Chemotherapy versus Best Supportive Care in Advanced Biliary Tract Carcinoma: A Multi-institutional Propensity Score Matching Analysis
por: Ji, Jun Ho, et al.
Publicado: (2018)

MerTK is a novel therapeutic target in gastric cancer
por: Yi, Jun Ho, et al.
Publicado: (2015)

High-Throughput Genotyping in Metastatic Esophageal Squamous Cell Carcinoma Identifies Phosphoinositide-3-Kinase and BRAF Mutations
por: Maeng, Chi Hoon, et al.
Publicado: (2012)

Tumor Mutational Burden as a Biomarker for Advanced Biliary Tract Cancer
por: Kim, Hongsik, et al.
Publicado: (2021)

High-Throughput Mutation Profiling Identifies Frequent Somatic Mutations in Advanced Gastric Adenocarcinoma
por: Lee, Jeeyun, et al.
Publicado: (2012)

Author Correction: High PD-L1 expression is associated with therapeutic response to pembrolizumab in patients with advanced biliary tract cancer
por: Ahn, Soomin, et al.
Publicado: (2020)

Aberrant CDK4 Amplification in Refractory Rhabdomyosarcoma as Identified by Genomic Profiling
por: Park, Silvia, et al.
Publicado: (2014)

Palliative endoscopic retrograde biliary drainage for malignant biliary obstruction in Korea: A nationwide assessment
por: Jang, Dong Kee, et al.
Publicado: (2021)

Comprehensive immunoprofile analysis of prognostic markers in pancreaticobiliary tract cancers
por: Kim, Ji Eun, et al.
Publicado: (2023)

Cystic Lesions of the Gastrointestinal Tract: Multimodality Imaging with Pathologic Correlations
por: Lee, Jongmee, et al.
Publicado: (2010)

NTRK1 rearrangement in colorectal cancer patients: evidence for actionable target using patient-derived tumor cell line
por: Lee, Su Jin, et al.
Publicado: (2015)

Identification of potential biomarkers for diagnosis of pancreatic and biliary tract cancers by sequencing of serum microRNAs
por: Kim, Kwondo, et al.
Publicado: (2019)

HER2 Aberrations as a Novel Marker in Advanced Biliary Tract Cancer
por: Kim, Hongsik, et al.
Publicado: (2022)

Centromere 17 copy number gain reflects chromosomal instability in breast cancer
por: Lee, Kyoungyul, et al.
Publicado: (2019)

Capecitabine plus Oxaliplatin as a Second-Line Therapy for Advanced Biliary Tract Cancers: A Multicenter, Open-Label, Phase II Trial
por: Kim, Seung Tae, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_e3vok0lsdjr5de7au6v8dehcdp